Current Status of Stereotactic Ablative Radiotherapy (SABR) for Early-stage 
Non-small Cell Lung Cancer

Current Status of Stereotactic Ablative Radiotherapy (SABR) for Early-stage 
Non-small Cell Lung Cancer

High level evidence from randomized studies comparing stereotactic ablative radiotherapy (SABR) to surgery is lacking. Although the results of pooled analysis of two randomized trials for STARS and ROSEL showed that SABR is better tolerated and might lead to better overall survival than surgery for...

Full description

Bibliographic Details
Main Authors: Anhui SHI, Guangying ZHU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2016-06-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lobectomy
Video-assisted thoracoscopic surgery
Lung neoplasms
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2016.06.18

Similar Items

Similar Items